脑膜瘤中TGF-β1、TGF-β2和TGF-β3在不同WHO级别间的差异表达:mRNA、甲基化、miRNA和蛋白质分析的汇聚证据
该前瞻性研究纳入154例WHO CNS5 1级脑膜内皮型(n=124)或2级非典型(n=30)脑膜瘤患者,通过RT-qPCR、甲基化特异性PCR、ELISA、Western blotting和免疫组化多层面分析TGF-β1-3。结果显示2级中TGF-β2和TGF-β3 mRNA显著上调(倍数5.68和5.23),TGF-β1 mRNA显著降低(倍数0.039),所有六个候选microRNA在2级协同下调,提示TGF-β2/TGF-β3轴和miR-200家族作为非典型脑膜瘤候选生物标志物。
要点
- 2级脑膜瘤中TGF-β2和TGF-β3 mRNA显著上调,TGF-β1 mRNA显著降低。
- 1级标本中TGF-β1-3启动子几乎均高甲基化(95-97%),2级多数未甲基化(73-77%)。
- 所有六个候选microRNA在2级协同下调,尤以miR-200a-3p/miR-141-3p为著。
核心结论
- 脑膜瘤中TGF-β失调呈现级别依赖、异构体特异性模式:转录、表观遗传和转录后信号汇聚于TGF-β2/TGF-β3轴,而TGF-β1 mRNA的 paradoxical 降低不能仅由甲基化状态解释。
研究设计与样本
- 前瞻性纳入两个神经外科中心的154例接受切除术的WHO CNS5 1级脑膜内皮型(n=124)或2级非典型(n=30)脑膜瘤患者。
主要发现
- 2级中TGF-β2和TGF-β3 mRNA显著上调(倍数分别为5.68和5.23),ELISA和IHC信号较高,但Western blot未证实。
- 2级中TGF-β1 mRNA显著降低(倍数0.039),蛋白减少,尽管启动子主要为未甲基化(76.7%未甲基化)。
- 1级标本中TGF-β1-3启动子几乎均高甲基化(95-97%),而2级多数未甲基化(73-77%)。
- 所有六个候选microRNA(尤以miR-200a-3p/miR-141-3p为著)在2级协同下调。
临床怎么用
- TGF-β2/TGF-β3轴和miR-200家族可作为非典型脑膜瘤的候选生物标志物,但需进一步验证。
- TGF-β1的调控机制独立于甲基化状态,值得功能学 follow-up 研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Meningiomas show biological heterogeneity not captured by WHO grading alone. TGF-β signaling has been implicated in meningioma pathobiology, yet a systematic, grade-stratified, isoform-resolved characterization of TGF-β1, TGF-β2, and TGF-β3 across transcriptional, epigenetic, post-transcriptional, and protein levels had not been performed. METHODS: We prospectively enrolled 154 patients undergoing resection of WHO CNS5 grade 1 meningothelial (n = 124) or grade 2 atypical (n = 30) meningioma across two neurosurgical centers. TGF-β1-3 mRNA and six bioinformatically prioritized targeting microRNAs were quantified by RT-qPCR; promoter methylation was assessed by methylation-specific PCR; protein abundance was measured by ELISA, Western blotting, and immunohistochemistry. RESULTS: TGF-β2 and TGF-β3 mRNA were markedly upregulated in grade 2 (fold-change 5.68 and 5.23, respectively), corroborated by higher ELISA and IHC signal, though not by Western blot. TGF-β1 mRNA expression was markedly reduced in grade 2 (fold-change 0.039) with reduced protein, despite a predominantly unmethylated promoter (76.7% unmethylated). Nearly all grade 1 specimens showed hypermethylated TGF-β1-3 promoters (95-97%), whereas most grade 2 specimens showed an unmethylated promoter (73-77%). All six candidate microRNAs, notably miR-200a-3p/miR-141-3p, were coordinately downregulated in grade 2. CONCLUSION: These findings show a grade-dependent, isoform-specific pattern of TGF-β dysregulation in meningioma: transcriptional, epigenetic, and post-transcriptional signals converge at the TGF-β2/TGF-β3 axis, alongside a paradoxical reduction in TGF-β1 mRNA that methylation status alone does not explain. This profile nominates TGF-β2/TGF-β3 and the miR-200 family as candidate biomarkers in atypical meningioma, while identifying TGF-β1 regulation as a distinct question for functional follow-up.
引用
- Miller M, Strojny D, Sobański D, et al. Differential expression of TGF-β1, TGF-β2, and TGF-β3 across WHO grades in meningioma: convergent evidence from mRNA, methylation, miRNA, and protein analysis. J Neurooncol. 2026. PMID: 42608612. doi:10.1007/s11060-026-05750-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。